CD40LG and B-cell chronic lymphocytic leukemia: The first clinical trial dates back to the 2000s, when autologous leukemic B cells isolated from chronic lymphocytic leukemia (CLL) patients were transduced to express the human CD40L or IL-2 gene prior to cell reinfusion.